[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![USCorpFilings Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1859110030752313345.png) SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4335 followers
Created: 2025-07-21 12:00:07 UTC

$SABS Equity Investments:

On July 21, 2025, SAB Biotherapeutics, Inc. entered into a securities purchase agreement to issue and sell XXXXXXXXX shares of Series B Preferred Stock and warrants, aiming to raise approximately $XXX million for its Phase 2b SAFEGUARD study and general purposes. The Preferred Stock will convert into common stock at $XXXX per share, subject to stockholder approval.




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947265329421590857/c:line.svg)

**Related Topics**
[seed funding](/topic/seed-funding)
[stocks](/topic/stocks)
[sab](/topic/sab)
[$sabs](/topic/$sabs)

[Post Link](https://x.com/USCorpFilings/status/1947265329421590857)